ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 7 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E0607Z | Introduction of Electrolytic and Water Balance Substance into Central Artery, Open Approach | Valid |
| 3E060FZ | Introduction of Intracirculatory Anesthetic into Central Artery, Open Approach | Valid |
| 3E060GC | Introduction of Other Therapeutic Substance into Central Artery, Open Approach | Valid |
| 3E060GN | Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Open Approach | Valid |
| 3E060HZ | Introduction of Radioactive Substance into Central Artery, Open Approach | Valid |
| 3E060KZ | Introduction of Other Diagnostic Substance into Central Artery, Open Approach | Valid |
| 3E060NZ | Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Open Approach | Valid |
| 3E060PZ | Introduction of Platelet Inhibitor into Central Artery, Open Approach | Valid |
| 3E060RZ | Introduction of Antiarrhythmic into Central Artery, Open Approach | Valid |
| 3E060TZ | Introduction of Destructive Agent into Central Artery, Open Approach | Valid |
| 3E060VG | Introduction of Insulin into Central Artery, Open Approach | Valid |
| 3E060VH | Introduction of Human B-type Natriuretic Peptide into Central Artery, Open Approach | Valid |
| 3E060VJ | Introduction of Other Hormone into Central Artery, Open Approach | Valid |
| 3E060WK | Introduction of Immunostimulator into Central Artery, Open | Valid |
| 3E060WL | Introduction of Immunosuppressive into Central Artery, Open | Valid |
| 3E060XZ | Introduction of Vasopressor into Central Artery, Open Approach | Valid |
| 3E06302 | Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach | Valid |
| 3E06303 | Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach | Valid |
| 3E06305 | Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach | Valid |
| 3E0630M | Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach | Valid |
| 3E0630P | Introduction of Clofarabine into Central Artery, Percutaneous Approach | Valid |
| 3E06316 | Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous | Valid |
| 3E06317 | Introduction of Other Thrombolytic into Central Artery, Percutaneous Approach | Valid |
| 3E06328 | Introduction of Oxazolidinones into Central Artery, Percutaneous Approach | Valid |
| 3E06329 | Introduction of Other Anti-infective into Central Artery, Percutaneous Approach | Valid |
| 3E0633Z | Introduction of Anti-inflammatory into Central Artery, Percutaneous Approach | Valid |
| 3E0634Z | Introduction of Serum, Toxoid and Vaccine into Central Artery, Percutaneous Approach | Valid |
| 3E0636Z | Introduction of Nutritional Substance into Central Artery, Percutaneous Approach | Valid |
| 3E0637Z | Introduction of Electrolytic and Water Balance Substance into Central Artery, Percutaneous Approach | Valid |
| 3E063FZ | Introduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approach | Valid |
| 3E063GC | Introduction of Other Therapeutic Substance into Central Artery, Percutaneous Approach | Valid |
| 3E063GN | Introduction of Blood Brain Barrier Disruption Substance into Central Artery, Percutaneous Approach | Valid |
| 3E063HZ | Introduction of Radioactive Substance into Central Artery, Percutaneous Approach | Valid |
| 3E063KZ | Introduction of Other Diagnostic Substance into Central Artery, Percutaneous Approach | Valid |
| 3E063NZ | Introduction of Analgesics, Hypnotics, Sedatives into Central Artery, Percutaneous Approach | Valid |
| 3E063PZ | Introduction of Platelet Inhibitor into Central Artery, Percutaneous Approach | Valid |
| 3E063RZ | Introduction of Antiarrhythmic into Central Artery, Percutaneous Approach | Valid |
| 3E063TZ | Introduction of Destructive Agent into Central Artery, Percutaneous Approach | Valid |
| 3E063VG | Introduction of Insulin into Central Artery, Percutaneous Approach | Valid |
| 3E063VH | Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach | Valid |
| 3E063VJ | Introduction of Other Hormone into Central Artery, Percutaneous Approach | Valid |
| 3E063WK | Introduction of Immunostimulator into Central Artery, Percutaneous | Valid |
| 3E063WL | Introduction of Immunosuppressive into Central Artery, Percutaneous | Valid |
| 3E063XZ | Introduction of Vasopressor into Central Artery, Percutaneous Approach | Valid |
| 3E07016 | Introduction of Recombinant Human-activated Protein C into Coronary Artery, Open | Valid |
| 3E07017 | Introduction of Other Thrombolytic into Coronary Artery, Open Approach | Valid |
| 3E070GC | Introduction of Other Therapeutic Substance into Coronary Artery, Open Approach | Valid |
| 3E070KZ | Introduction of Other Diagnostic Substance into Coronary Artery, Open Approach | Valid |
| 3E070PZ | Introduction of Platelet Inhibitor into Coronary Artery, Open Approach | Valid |
| 3E07316 | Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous | Valid |
| 3E07317 | Introduction of Other Thrombolytic into Coronary Artery, Percutaneous Approach | Valid |
| 3E073GC | Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Approach | Valid |
| 3E073KZ | Introduction of Other Diagnostic Substance into Coronary Artery, Percutaneous Approach | Valid |
| 3E073PZ | Introduction of Platelet Inhibitor into Coronary Artery, Percutaneous Approach | Valid |
| 3E074GC | Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Endoscopic Approach | Valid |
| 3E08016 | Introduction of Recombinant Human-activated Protein C into Heart, Open | Valid |
| 3E08017 | Introduction of Other Thrombolytic into Heart, Open Approach | Valid |
| 3E080GC | Introduction of Other Therapeutic Substance into Heart, Open Approach | Valid |
| 3E080KZ | Introduction of Other Diagnostic Substance into Heart, Open Approach | Valid |
| 3E080PZ | Introduction of Platelet Inhibitor into Heart, Open Approach | Valid |
| 3E08316 | Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous | Valid |
| 3E08317 | Introduction of Other Thrombolytic into Heart, Percutaneous Approach | Valid |
| 3E083GC | Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach | Valid |
| 3E083KZ | Introduction of Other Diagnostic Substance into Heart, Percutaneous Approach | Valid |
| 3E083PZ | Introduction of Platelet Inhibitor into Heart, Percutaneous Approach | Valid |
| 3E084GC | Introduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach | Valid |
| 3E09305 | Introduction of Other Antineoplastic into Nose, Percutaneous Approach | Valid |
| 3E0930M | Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach | Valid |
| 3E09328 | Introduction of Oxazolidinones into Nose, Percutaneous Approach | Valid |
| 3E09329 | Introduction of Other Anti-infective into Nose, Percutaneous Approach | Valid |
| 3E0933Z | Introduction of Anti-inflammatory into Nose, Percutaneous Approach | Valid |
| 3E0934Z | Introduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach | Valid |
| 3E093BZ | Introduction of Anesthetic Agent into Nose, Percutaneous Approach | Valid |
| 3E093GC | Introduction of Other Therapeutic Substance into Nose, Percutaneous Approach | Valid |
| 3E093HZ | Introduction of Radioactive Substance into Nose, Percutaneous Approach | Valid |
| 3E093KZ | Introduction of Other Diagnostic Substance into Nose, Percutaneous Approach | Valid |
| 3E093NZ | Introduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach | Valid |
| 3E093TZ | Introduction of Destructive Agent into Nose, Percutaneous Approach | Valid |
| 3E09705 | Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening | Valid |
| 3E0970M | Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening | Valid |
| 3E09728 | Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening | Valid |
| 3E09729 | Introduction of Other Anti-infective into Nose, Via Natural or Artificial Opening | Valid |
| 3E0973Z | Introduction of Anti-inflammatory into Nose, Via Natural or Artificial Opening | Valid |
| 3E0974Z | Introduction of Serum, Toxoid and Vaccine into Nose, Via Natural or Artificial Opening | Valid |
| 3E097BZ | Introduction of Anesthetic Agent into Nose, Via Natural or Artificial Opening | Valid |
| 3E097GC | Introduction of Other Therapeutic Substance into Nose, Via Natural or Artificial Opening | Valid |
| 3E097HZ | Introduction of Radioactive Substance into Nose, Via Natural or Artificial Opening | Valid |
| 3E097KZ | Introduction of Other Diagnostic Substance into Nose, Via Natural or Artificial Opening | Valid |
| 3E097NZ | Introduction of Analgesics, Hypnotics, Sedatives into Nose, Via Natural or Artificial Opening | Valid |
| 3E097TZ | Introduction of Destructive Agent into Nose, Via Natural or Artificial Opening | Valid |
| 3E09X05 | Introduction of Other Antineoplastic into Nose, External Approach | Valid |
| 3E09X0M | Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach | Valid |
| 3E09X28 | Introduction of Oxazolidinones into Nose, External Approach | Valid |
| 3E09X29 | Introduction of Other Anti-infective into Nose, External Approach | Valid |
| 3E09X3Z | Introduction of Anti-inflammatory into Nose, External Approach | Valid |
| 3E09X4Z | Introduction of Serum, Toxoid and Vaccine into Nose, External Approach | Valid |
| 3E09XBZ | Introduction of Anesthetic Agent into Nose, External Approach | Valid |
| 3E09XGC | Introduction of Other Therapeutic Substance into Nose, External Approach | Valid |
| 3E09XHZ | Introduction of Radioactive Substance into Nose, External Approach | Valid |
| 3E09XKZ | Introduction of Other Diagnostic Substance into Nose, External Approach | Valid |